142 related articles for article (PubMed ID: 16581570)
1. Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity.
van de Kerkhof PC; Kragballe K; Austad J; Berth-Jones J; Cambazard F; de la Brassinne M; Ljungberg A; Murphy G; Papp K; Wozel G
Eur J Dermatol; 2006; 16(2):167-71. PubMed ID: 16581570
[TBL] [Abstract][Full Text] [Related]
2. Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients.
Bruins FM; Bronckers IMGJ; Groenewoud HMM; van de Kerkhof PCM; de Jong EMGJ; Seyger MMB
JAMA Dermatol; 2020 Jan; 156(1):72-78. PubMed ID: 31774449
[TBL] [Abstract][Full Text] [Related]
3. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
4. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
Bożek A; Reich A
Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
[TBL] [Abstract][Full Text] [Related]
5. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
Jacobson CC; Kimball AB
Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
[TBL] [Abstract][Full Text] [Related]
7. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
[TBL] [Abstract][Full Text] [Related]
8. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin for the treatment of plaque-type psoriasis.
Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
[TBL] [Abstract][Full Text] [Related]
10. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters.
Armstrong AW; Parsi K; Schupp CW; Mease PJ; Duffin KC
JAMA Dermatol; 2013 May; 149(5):577-82. PubMed ID: 23426158
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.
Huang K; Wu X; Li Y; Lv C; Yan Y; Wu Z; Zhang M; Huang W; Jiang Z; Hu K; Li M; Su J; Zhu W; Li F; Chen M; Chen J; Li Y; Zeng M; Zhu J; Cao D; Huang X; Huang L; Hu X; Chen Z; Kang J; Yuan L; Huang C; Guo R; Navarini A; Kuang Y; Chen X; Zhao S
J Med Internet Res; 2023 Mar; 25():e44932. PubMed ID: 36927843
[TBL] [Abstract][Full Text] [Related]
12. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
13. Defining and treating moderate plaque psoriasis: a dermatologist survey.
Knuckles MLF; Levi E; Soung J
J Dermatolog Treat; 2018 Nov; 29(7):658-663. PubMed ID: 29502473
[TBL] [Abstract][Full Text] [Related]
14. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
Bergstrom KG; Arambula K; Kimball AB
Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
[TBL] [Abstract][Full Text] [Related]
15. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
[TBL] [Abstract][Full Text] [Related]
16. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis.
Robinson A; Kardos M; Kimball AB
J Am Acad Dermatol; 2012 Mar; 66(3):369-75. PubMed ID: 22041254
[TBL] [Abstract][Full Text] [Related]
17. Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI).
Matza LS; Brazier JE; Stewart KD; Pinto L; Bender RH; Kircik L; Jordan J; Kim KJ; Mutebi A; Viswanathan HN; Menter A
J Med Econ; 2019 Sep; 22(9):936-944. PubMed ID: 31161828
[No Abstract] [Full Text] [Related]
18. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
19. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
[TBL] [Abstract][Full Text] [Related]
20. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]